iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
 
 
OCA Obeticholic Acid Update at NASH-TAG Jan 5 2023
 
 
  AASLD: Intercept Announces Additional Positive Data in Fibrosis due to NASH from New Analysis of Phase 3 REGENERATE Study at AASLD The Liver Meeting® 2022 - (11/28/22)
 
AASLD: Topline Results From a New Analysis of the REGENERATE Trial of Obeticholic Acid for the Treatment of Nonalcoholic Steatohepatitis - (11/28/22)
 
 Presented at the NASH-TAG Conference held from January 5 - 7, 2023, in Park City, Utah.
 

0118231

0118232

0118233

0118234

0118235

0118236

0118237

0118238

0118239

01182310

01182311

01182312

01182313

01182314

01182315

  
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org